ATE377602T1 - Morphinanderivate und ihre medizinische anwendung - Google Patents

Morphinanderivate und ihre medizinische anwendung

Info

Publication number
ATE377602T1
ATE377602T1 AT98911044T AT98911044T ATE377602T1 AT E377602 T1 ATE377602 T1 AT E377602T1 AT 98911044 T AT98911044 T AT 98911044T AT 98911044 T AT98911044 T AT 98911044T AT E377602 T1 ATE377602 T1 AT E377602T1
Authority
AT
Austria
Prior art keywords
morphinan derivatives
medical applications
morphinan
derivatives
opioid
Prior art date
Application number
AT98911044T
Other languages
English (en)
Inventor
Hiroshi Nagase
Hideaki Fujii
Takashi Endoh
Koji Kawai
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Application granted granted Critical
Publication of ATE377602T1 publication Critical patent/ATE377602T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT98911044T 1997-03-27 1998-03-27 Morphinanderivate und ihre medizinische anwendung ATE377602T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7634097 1997-03-27

Publications (1)

Publication Number Publication Date
ATE377602T1 true ATE377602T1 (de) 2007-11-15

Family

ID=13602637

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98911044T ATE377602T1 (de) 1997-03-27 1998-03-27 Morphinanderivate und ihre medizinische anwendung

Country Status (12)

Country Link
US (1) US6187782B1 (de)
EP (1) EP0915094B1 (de)
KR (1) KR20000016052A (de)
CN (1) CN1150196C (de)
AT (1) ATE377602T1 (de)
AU (1) AU743929B2 (de)
CA (1) CA2256897C (de)
DE (1) DE69838662T2 (de)
ES (1) ES2297882T3 (de)
NO (1) NO985518L (de)
NZ (1) NZ333101A (de)
WO (1) WO1998043978A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1204139C (zh) * 1999-08-24 2005-06-01 东丽株式会社 神经性疼痛治疗剂
AU2007313103C1 (en) 2006-10-17 2014-01-30 Penick Corporation Process for preparing oxymorphone
US20080125592A1 (en) 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
CA2674915C (en) 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
AU2012216358B2 (en) * 2006-10-17 2014-11-20 Penick Corporation Process For Preparing Oxymorphone, Naltrexone and Buprenorphine
EP2357183B1 (de) 2007-05-01 2015-07-01 Concert Pharmaceuticals Inc. Morphinan Verbindungen
MX370608B (es) 2007-05-01 2019-12-18 Concert Pharmaceuticals Inc Compuestos de morfinano.
JP5252391B2 (ja) * 2008-02-21 2013-07-31 学校法人北里研究所 オキサビシクロ［２．２．２］オクタンを有するモルヒナン誘導体およびその医薬用途
EP2303897A4 (de) 2008-06-05 2012-02-22 Harvard College Hochvalente palladiumfluoridkomplexe und anwendungen davon
CA2740476C (en) * 2008-10-24 2016-04-05 Toray Industries, Inc. Stable tablet containing 4,5-epoxymorphinan derivative
WO2010059943A2 (en) 2008-11-20 2010-05-27 President And Fellows Of Harvard College Fluorination of organic compounds
WO2010081034A2 (en) * 2009-01-09 2010-07-15 President And Fellows Of Harvard College Fluorine containing compounds and methods of use thereof
JP2014073964A (ja) * 2011-01-28 2014-04-24 Kitasato Institute モルヒナン誘導体
US9150516B2 (en) 2011-04-12 2015-10-06 President And Fellows Of Harvard College Fluorination of organic compounds
JP6061857B2 (ja) 2011-09-09 2017-01-18 学校法人北里研究所 モルヒナン誘導体
WO2014021273A1 (ja) * 2012-07-30 2014-02-06 学校法人北里研究所 モルヒナン誘導体
US9273083B2 (en) 2012-09-26 2016-03-01 President And Fellows Of Harvard College Nickel fluorinating complexes and uses thereof
AU2013369037C1 (en) 2012-12-31 2017-06-08 Rhodes Technologies Process for preparing 7beta-substituted 6alpha,14alpha -ethenomorphinans and 7beta-substituted 6alpha,14alpha-ethanomorphinans
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
WO2015058047A2 (en) 2013-10-18 2015-04-23 President And Fellows Of Harvard College Fluorination of organic compounds
JP6814470B2 (ja) * 2017-02-10 2021-01-20 国立大学法人 筑波大学 モルヒナン誘導体
JPWO2019045006A1 (ja) * 2017-08-31 2020-10-01 国立大学法人 筑波大学 モルヒナン誘導体
WO2019168025A1 (ja) * 2018-02-28 2019-09-06 日本ケミファ株式会社 モルヒナン誘導体の製造方法
JP2021104932A (ja) * 2018-03-30 2021-07-26 日本ケミファ株式会社 モルヒナン誘導体の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2229770A1 (de) 1972-06-19 1974-01-10 Boehringer Sohn Ingelheim N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
JPS6163658A (ja) 1984-07-05 1986-04-01 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー ３−ヒドロキシモルフイナン類の置換ベンゾエ−トエステルプロドラツグ誘導体
PT95069B (pt) 1989-08-24 1997-10-31 Searle & Co Processo para a preparacao de (+)-isomeros de derivados de endoetano/endoetanoepoximofinano, uteis como agentes anti-tussicos
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.

Also Published As

Publication number Publication date
NO985518L (no) 1999-01-21
CN1220667A (zh) 1999-06-23
EP0915094B1 (de) 2007-11-07
DE69838662D1 (de) 2007-12-20
AU6518998A (en) 1998-10-22
CN1150196C (zh) 2004-05-19
DE69838662T2 (de) 2008-08-28
US6187782B1 (en) 2001-02-13
KR20000016052A (ko) 2000-03-25
ES2297882T3 (es) 2008-05-01
EP0915094A4 (de) 2004-09-22
NO985518D0 (no) 1998-11-26
CA2256897A1 (en) 1998-10-08
NZ333101A (en) 2000-05-26
WO1998043978A1 (en) 1998-10-08
EP0915094A1 (de) 1999-05-12
CA2256897C (en) 2006-10-03
AU743929B2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
DK1004578T3 (da) 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
EA200301306A1 (ru) Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
ATE212978T1 (de) Para-substituierte phenylpropansäure derivate als integrin-antagonisten
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
EA200200716A1 (ru) Арилконденсированные азаполициклические соединения
ATE413388T1 (de) Muskarin antagonisten
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
EA200400467A1 (ru) Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
NO20032261D0 (no) Medisinske preparater
ATE318266T1 (de) 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten
PT992509E (pt) Novos derivados macrolidos
ATE498600T1 (de) Inden derivate als pharmazeutika
EA200301203A1 (ru) Новые соединения и композиции как ингибиторы катепсина
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
CA2356985A1 (en) 5ht1 antagonists for antidepressant therapy
ATE427310T1 (de) Kondensierte bicyclische pyrimidinderivate
WO2001010860A3 (en) Quinazolinone and azaquinazolinone derivatives
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
BR0317363A (pt) Antagonista de npy-5

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties